453 Results

People

  1. Kelsen
    Kelsen
  2. Motzer
    Motzer
  3. Kris
    Kris
  4. Saltz
    Saltz
  5. Abrey
    Abrey
  6. O'Reilly
    O'Reilly
  7. Schwartz
    Schwartz
  8. Hudis
    Hudis
  9. Aghajanian
    Aghajanian
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)
  7. Center for Hematologic Malignancies (63)
  8. Epidemiology and Biostatistics (61)
  9. Biostatistics Service (60)
  10. Genitourinary Oncology Service (59)
  1. "leukopenia"
Formats
  1. Journal Article (435)
  2. Review (9)
  3. Conference Paper (4)
  4. Editorial (2)
  5. Research Letter (2)
  6. Miscellaneous (1)
Groups
  1. Department of Medicine (312)
  2. Solid Tumor Oncology Division (250)
  3. Survivorship Research (79)
  4. Gastrointestinal Oncology Service (76)
  5. Hematologic Malignancies, Division of (76)
  6. Radiology, Department of (64)

More Groups

People
  1. David Kelsen (33)
  2. Robert Motzer (29)
  3. Mark Kris (25)
  4. Leonard Saltz (21)
  5. Eileen O'Reilly (18)
  6. Lauren Abrey (18)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Cancer (33)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (15)
  5. Gynecologic Oncology (14)
  6. Investigational New Drugs (14)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Springer (52)
  3. American Society of Clinical Oncology (43)
  4. Wiley Blackwell (39)
  5. American Association for Cancer Research (36)
  6. Oxford University Press (33)

More Publishers

Results (453)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia
    Journal Article

    Strickland, S. A.; Wang, X. V.; Cerny, J.; Rowe, J. M.; Rybka, W.; Tallman, M. S.; Litzow, M.; Lazarus, H. M.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
    Research Letter

    Sawas, A.; Ma, H.; Shustov, A.; Hsu, P.; Bhat, G.; Acosta, M.; Horwitz, S.; O’Connor, O. A.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
    Journal Article

    Ikeda, T.; Takemoto, S.; Senju, H.; Gyotoku, H.; Taniguchi, H.; Shimada, M.; Dotsu, Y.; Umeyama, Y.; Tomono, H.; Kitazaki, T.; more...
    Thoracic Cancer (2020)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?
    Research Letter

    Nawar, T.; Morjaria, S.; Kaltsas, A.; Patel, D.; Perez-Johnston, R.; Daniyan, A. F.; Mailankody, S.; Parameswaran, R.
    American Journal of Hematology (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
    Journal Article

    Noel, M.; O’Reilly, E. M.; Wolpin, B. M.; Ryan, D. P.; Bullock, A. J.; Britten, C. D.; Linehan, D. C.; Belt, B. A.; Gamelin, E. C.; Ganguly, B.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: The ANNOUNCE randomized clinical trial
    Journal Article

    Tap, W. D.; Wagner, A. J.; Schöffski, P.; Martin-Broto, J.; Krarup-Hansen, A.; Ganjoo, K. N.; Yen, C. C.; Abdul Razak, A. R.; Spira, A.; Kawai, A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Phase I study of trifluridine/tipiracil plus irinotecan and bevacizumab in advanced gastrointestinal tumors
    Journal Article

    Varghese, A. M.; Cardin, D. B.; Hersch, J.; Benson, A. B.; Hochster, H. S.; Makris, L.; Hamada, K.; Berlin, J. D.; Saltz, L. B.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma
    Journal Article

    van Brummelen, E. M. J.; Levchenko, E.; Dómine, M.; Fennell, D. A.; Kindler, H. L.; Viteri, S.; Gadgeel, S.; López, P. G.; Kostorov, V.; Morgensztern, D.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save